Literature DB >> 809079

Cardiovascular depressant effects of neomycin and gentamicin in rhesus monkeys.

H R Adams.   

Abstract

1. The acute cardiovascular effects of neomycin and gentamicin, representative aminoglycoside antibiotics, were examined in surgically-prepared anaesthetized rhesus monkeys. 2. Intravenous administration of 14, 28, and 56 mg/kg of neomycin consistently induced a dose-dependent depression of systemic blood pressure, cardiac output, left ventricular contractile force, maximum dF/dt of left ventricular contraction, and heart rate. Neomycin produced similar cardiovascular depressant effects when heart rate was maintained constant by electrical pacing. 3. Maximum depression of haemodynamic values usually occurred within 2 to 5 min after injection of neomycin; values then gradually returned to control levels within 20 to 30 (14 mg/kg) or 60 to 80 (56 mg/kg) minutes. 4. Injection of CaCl2 (1.35 mEq Ca2+/kg, i.v.) during the peak depressant effect of neomycin produced a rapid and maintained restoration of cardiovascular function to control levels; conversely, noradrenaline (2 mug, i.v.) of isoprenaline (0.5 mug, i.v.) produced only transient reversal of the neomycin effects. 5. Similar evidence of cardiovascular dysfunction was observed with gentamicin. 6. These findings demonstrate the direct cardiovascular depressant effects of aminoglycoside natibiotics in a higher primate species, and suggest that this adverse response is related to an alteration of calcium ion function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809079      PMCID: PMC1666674          DOI: 10.1111/j.1476-5381.1975.tb07591.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Respiratory paralysis after a large dose of streptomycin. Report of a case.

Authors:  G C FISK
Journal:  Br Med J       Date:  1961-02-25

2.  The neuromuscular blocking action of neomycin: a concern of the anesthesiologist.

Authors:  C B PITTINGER; J P LONG; J R MILLER
Journal:  Anesth Analg       Date:  1958 Sep-Oct       Impact factor: 5.108

Review 3.  Calcium-membrane interactions in the myocardium: effects of ouabain, epinephrine and 3',5'-cyclic adenosine monophosphate.

Authors:  A M Katz; D I Repke
Journal:  Am J Cardiol       Date:  1973-02       Impact factor: 2.778

Review 4.  Antibiotic-induced paralysis.

Authors:  C B Pittinger; Y Eryasa; R Adamson
Journal:  Anesth Analg       Date:  1970 May-Jun       Impact factor: 5.108

5.  Neuromuscular blockade associated with gentamicin therapy.

Authors:  W A Warner; E Sanders
Journal:  JAMA       Date:  1971-02-15       Impact factor: 56.272

6.  Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery.

Authors:  R Rosenblum; J Frieden
Journal:  Am Heart J       Date:  1972-06       Impact factor: 4.749

7.  Effects of acute lactic acidosis on left ventricular performance.

Authors:  K Wildenthal; D S Mierzwiak; R W Myers; J H Mitchell
Journal:  Am J Physiol       Date:  1968-06

8.  Alterations by neomycin of 45Ca movements and contractile responses in vascular smooth muscle.

Authors:  F R Goodman; G B Weiss; H R Adams
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

9.  Effect of inotropic agents on canine trabecular muscle rendered highly permeable to calcium.

Authors:  W G Nayler
Journal:  Am J Physiol       Date:  1973-10

10.  Alteration of contractile function and calcium ion movements in vascular smooth muscle by gentamicin and other aminoglycoside antibiotics.

Authors:  H R Adams; F R Goodman; G B Weiss
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

View more
  2 in total

1.  Inhibition of the slow inward current and the time-dependent outward current of mammalian ventricular muscle by gentamicin.

Authors:  N Hino; R Ochi; T Yanagisawa
Journal:  Pflugers Arch       Date:  1982-09       Impact factor: 3.657

2.  Cardiac toxicities of antibiotics.

Authors:  H R Adams; J L Parker; L R Durrett
Journal:  Environ Health Perspect       Date:  1978-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.